Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
February 13, 2026
Aldosterone and the Mineralocorticoid Receptor in Atrial Fibrillation
Argen Mamazhakypov, Remi Peyronnet, Achim Lother
British Journal of Pharmacology
|
February 17, 2022
Emerging fields for therapeutic targeting of the aldosterone-mineralocorticoid receptor signaling pathway
Achim Lother, Frédéric Jaisser, Ulrich O Wenzel
Journal of Intensive Care Medicine
|
May 25, 2019
Tracheostomy in Patients on Extracorporeal Membrane Oxygenation: Is it Really Safe?
Achim Lother, Christoph Bode, Dawid L Staudacher
American Journal of Hypertension
|
November 17, 2020
Response to "How Important Is the Assessment of Soluble ACE-2 in COVID-19?"
Marina Rieder, Christoph Bode, Daniel Duerschmied, et al.
The Journal of Infectious Diseases
|
May 6, 2021
Reply to Panda et al
Marina Rieder, Daniel Duerschmied, Christoph Bode, et al.
Basic Research in Cardiology
|
May 7, 2011
Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis
Johanna Schneider, Achim Lother, Lutz Hein, et al.
Intensive Care Medicine Experimental
|
May 11, 2024
Catecholamine treatment induces reversible heart injury and cardiomyocyte gene expression
Christine Bode, Sebastian Preissl, Lutz Hein, et al.
British Journal of Pharmacology
|
October 26, 2021
Approaches towards tissue-selective pharmacology of the mineralocorticoid receptor
Dorien Clarisse, Lisa Deng, Karolien de Bosscher, et al.
Critical Care (London, England)
|
August 22, 2020
Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
Alexander Supady, Daniel Duerschmied, Christoph Bode, et al.
Annual Review of Pharmacology and Toxicology
|
September 25, 2014
Mineralocorticoids in the heart and vasculature: new insights for old hormones
Achim Lother, Martin Moser, Christoph Bode, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Hypertension (Dallas, Tex. : 1979)
|
February 13, 2026
Aldosterone and the Mineralocorticoid Receptor in Atrial Fibrillation
Argen Mamazhakypov, Remi Peyronnet, Achim Lother
British Journal of Pharmacology
|
February 17, 2022
Emerging fields for therapeutic targeting of the aldosterone-mineralocorticoid receptor signaling pathway
Achim Lother, Frédéric Jaisser, Ulrich O Wenzel
Journal of Intensive Care Medicine
|
May 25, 2019
Tracheostomy in Patients on Extracorporeal Membrane Oxygenation: Is it Really Safe?
Achim Lother, Christoph Bode, Dawid L Staudacher
American Journal of Hypertension
|
November 17, 2020
Response to "How Important Is the Assessment of Soluble ACE-2 in COVID-19?"
Marina Rieder, Christoph Bode, Daniel Duerschmied, et al.
The Journal of Infectious Diseases
|
May 6, 2021
Reply to Panda et al
Marina Rieder, Daniel Duerschmied, Christoph Bode, et al.
Basic Research in Cardiology
|
May 7, 2011
Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis
Johanna Schneider, Achim Lother, Lutz Hein, et al.
Intensive Care Medicine Experimental
|
May 11, 2024
Catecholamine treatment induces reversible heart injury and cardiomyocyte gene expression
Christine Bode, Sebastian Preissl, Lutz Hein, et al.
British Journal of Pharmacology
|
October 26, 2021
Approaches towards tissue-selective pharmacology of the mineralocorticoid receptor
Dorien Clarisse, Lisa Deng, Karolien de Bosscher, et al.
Critical Care (London, England)
|
August 22, 2020
Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
Alexander Supady, Daniel Duerschmied, Christoph Bode, et al.
Annual Review of Pharmacology and Toxicology
|
September 25, 2014
Mineralocorticoids in the heart and vasculature: new insights for old hormones
Achim Lother, Martin Moser, Christoph Bode, et al.
Page
of 8